MedTrace Logo

Pitavastatin on Carotid Intima-media Thickness

NCT00711919 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2009-09-10

No results posted yet for this study

Summary

This study is aimed to analyze the effects of aggressive and conventional lipid lowering therapy with Pravastatin on carotid intima-media thickness (IMT) in patients with hyperlipidemia and abnormal thickening of IMT.

Conditions

Interventions

DRUG

Pitavastatin

comparison of different target levels of lipid lowering using Pitavastatin Subjects are receiving Pitavastatin, starting at 2 mg, for 12 months.

DRUG

Pitavastatin

Subjects are receiving Pitavastatin, starting at 4 mg, for 12 months.

Sponsors & Collaborators

  • Kyoto Prefectural University of Medicine

    lead OTHER

Principal Investigators

  • Hiroaki Matsubara, MD, PhD · Kyoto Prefectural University of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2009-12-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00711919 on ClinicalTrials.gov